87 related articles for article (PubMed ID: 18673462)
1. Germline mutations in the CDKN1B gene encoding p27 Kip1 are a rare cause of multiple endocrine neoplasia type 1.
Owens M; Stals K; Ellard S; Vaidya B
Clin Endocrinol (Oxf); 2009 Mar; 70(3):499-500. PubMed ID: 18673462
[No Abstract] [Full Text] [Related]
2. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
3. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
[TBL] [Abstract][Full Text] [Related]
4. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.
Pellegata NS; Quintanilla-Martinez L; Siggelkow H; Samson E; Bink K; Höfler H; Fend F; Graw J; Atkinson MJ
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15558-63. PubMed ID: 17030811
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.
Malanga D; De Gisi S; Riccardi M; Scrima M; De Marco C; Robledo M; Viglietto G
Eur J Endocrinol; 2012 Mar; 166(3):551-60. PubMed ID: 22129891
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
Karhu A; Aaltonen LA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R73-9. PubMed ID: 17613551
[TBL] [Abstract][Full Text] [Related]
7. Gene dose mapping delineated boundaries of a large germline deletion responsible for multiple endocrine neoplasia type 1.
Kikuchi M; Ohkura N; Yamaguchi K; Obara T; Tsukada T
Cancer Lett; 2004 May; 208(1):81-8. PubMed ID: 15105049
[TBL] [Abstract][Full Text] [Related]
8. A germline mutation in a Thai family with familial multiple endocrine neoplasia type 1.
Snabboon T; Plengpanich W; Shotelersuk V; Sirisalipoch S; Nonthasoot B; Sirichindakul B; Wisedopas N; Suwanwalaikorn S
J Med Assoc Thai; 2005 Feb; 88(2):191-5. PubMed ID: 15962670
[TBL] [Abstract][Full Text] [Related]
9. A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1.
Fukuuchi A; Nagamura Y; Yaguchi H; Ohkura N; Obara T; Tsukada T
Jpn J Clin Oncol; 2006 Nov; 36(11):739-44. PubMed ID: 17000701
[TBL] [Abstract][Full Text] [Related]
10. A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization.
Molatore S; Marinoni I; Lee M; Pulz E; Ambrosio MR; degli Uberti EC; Zatelli MC; Pellegata NS
Hum Mutat; 2010 Nov; 31(11):E1825-35. PubMed ID: 20824794
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 1.
Skogseid B
Br J Surg; 2003 Apr; 90(4):383-5. PubMed ID: 12673737
[No Abstract] [Full Text] [Related]
12. Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report.
Papi L; Palli D; Masi L; Putignano AL; Congregati C; Zanna I; Marini F; Giusti F; Luzi E; Tonelli F; Genuardi M; Brandi ML; Falchetti A
Cancer Genet Cytogenet; 2009 Nov; 195(1):75-9. PubMed ID: 19837273
[TBL] [Abstract][Full Text] [Related]
13. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V;
J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098
[TBL] [Abstract][Full Text] [Related]
15. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
[TBL] [Abstract][Full Text] [Related]
16. Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention.
Lim LC; Tan MH; Eng C; Teh BT; Rajasoorya RC
J Intern Med; 2006 Apr; 259(4):428-32. PubMed ID: 16594911
[TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasia type I variants and phenocopies: more than a nosological issue?
Falchetti A; Brandi ML
J Clin Endocrinol Metab; 2009 May; 94(5):1518-20. PubMed ID: 19420274
[No Abstract] [Full Text] [Related]
18. [Identification of the MEN-(multiple endocrine neoplasia)1-gene: clinical and scientific relevance].
Simon B; Eissele R
Z Gastroenterol; 1998 Sep; 36(9):867-9. PubMed ID: 9795418
[No Abstract] [Full Text] [Related]
19. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.
Brems H; Chmara M; Sahbatou M; Denayer E; Taniguchi K; Kato R; Somers R; Messiaen L; De Schepper S; Fryns JP; Cools J; Marynen P; Thomas G; Yoshimura A; Legius E
Nat Genet; 2007 Sep; 39(9):1120-6. PubMed ID: 17704776
[TBL] [Abstract][Full Text] [Related]
20. Genetics of phaeochromocytoma.
Maher ER
Br Med Bull; 2006; 79-80():141-51. PubMed ID: 17339275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
